Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis | Discovery | - | 29 Aug 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 29 Aug 2025 | |
| Inflammation | Discovery | - | 29 Aug 2025 | |
| Neoplasms | Discovery | - | 29 Aug 2025 | |
| Neurodegenerative Diseases | Discovery | - | 29 Aug 2025 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 29 Aug 2025 |





